Overview
PEPS ranks this pair inside the Top 300 market-cap universe. That means Injective and XPL are liquid enough for an indexable comparison, with metrics refreshed on the hourly coin pipeline.
Quick winners
Full comparison
| Metric | INJ | XPL |
|---|---|---|
| Price | $5.13 | $0.076700 |
| Market Cap | $490.41M | $206.04M |
| FDV | — | — |
| Volume 24h | $2.59M | $2.25M |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 99.00 | 158.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +5.97% | +3.64% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | INJ | XPL |
|---|---|---|
| 1H | — | — |
| 24H | +3.91% | +2.54% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | INJ | XPL |
|---|---|---|
| RSI | 49.29 | 49.02 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 0.29 | 67.35 |
| ADX | 12.19 | 21.33 |
| Support | 4.91 | 1,827.82 |
| Resistance | 5.47 | 1,960.30 |
| Trend | neutral | bearish |
| Momentum | — | 59.00 |
| Signal | neutral | neutral |
Automatic technical analysis
When RSI and trend disagree across Injective and XPL, expect choppy relative performance until one side reclaims a clear structure.
Fundamentals
| Metric | INJ | XPL |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | 0.00 | — |
| Github activity | 118.00 | — |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
Injective
XPL
Pros and cons
Pros of Injective
- Higher ranking for Injective can translate into tighter spreads on major venues.
- Market-cap scale on Injective may dampen some idiosyncratic shocks versus smaller peers.
Cons of Injective
- Regulatory or macro headlines can hit Injective harder simply because it is more visible.
- When dominance narratives fade, Injective can lag hotter rotation names.
- Data gaps in niche fundamentals still apply — absence of a field is not confirmation.
Pros of XPL
- Diversifying versus Injective with XPL can change portfolio factor exposure.
- Active volume bursts on XPL sometimes precede sharper tactical moves.
- XPL can offer higher relative beta when market attention rotates toward its niche.
- Narrative optionality around XPL can reprice quickly when catalysts appear.
Cons of XPL
- Trend failures on XPL often travel faster than on more established assets.
- Higher volatility on XPL cuts both ways and demands stricter risk limits.
Which looks stronger right now?
The “stronger” label here is descriptive, not predictive. Injective and XPL can alternate leadership as macro liquidity and narrative rotate.
AI summary
Comparing INJ and XPL begins with structure: capitalization, volume and rank. Present prints are $5.13 versus $0.076700. Momentum and trend can disagree with market-cap hierarchy. That is normal in crypto rotations and should be stress-tested against supports and news flow. Canonical URLs prevent duplicate XPL-vs-INJ pages, keeping SEO equity on one comparison. Keep monitoring winners as data updates.
FAQ
Which is better, Injective or XPL?
“Better” depends on horizon and risk. Injective leads on market cap today, while Injective leads the 24h move — neither is a guarantee.
Which has more upside potential, INJ or XPL?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both Injective and XPL.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. Injective currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is Injective, but longer windows can disagree.